Prevalence of Polypoidal Choroidal Vasculopathy Beyond Recalcitrant Macular Neovasculopathies in a European AMD Cohort and Therapeutic Response to Brolucizumab

Retinal Diseases

Faricimab for Polypoidal Choroidal Vasculopathy: 48-Week Results from the Phase 3b/4 SALWEEN Trial

Ophthalmol Retina

Cheung CMG, Lee WK, Chen SJ, Iida T, Lee J, Li X, Sun X, Ruamviboonsuk P, Koh AHC, Yanagi Y, Bai R, Duc AN, Margaron P, Lai TYY

doi: 10.1016/j.oret.2026.08.003

Further Publications

Aflibercept 8 mg in Polypoidal Choroidal Vasculopathy: Post Hoc Analysis of the PULSAR Randomized Clinical Trial

JAMA Ophthalmol

Lee WK, Wong TY, Chen SJ, Sun X, Cheung CMG, Silva R, Ricci F, Zhang X, Machewitz T, Schulze A, Schmidt-Ott UM, Zhao M, Hasanbasic Z, Leal S, Iida T, PULSAR Study Investigators

doi: 10.1001/jamaophthalmol.2025.5098

Macular Diseases

Beyond Central Subfield Thickness: Early Multi-Slice Optical Coherence Tomography Structural Response After Faricimab Injection in Real-World Diabetic Macular Edema

J Clin Med

Liu DY, Wu SL, Hsia NY, Tien PT, Lin CJ, Wang I, Lai CT, Lin JM, Huang YT, Wu BQ, Lin WN, Ku WN, Meng PP, Chen HS, Tsai YY

doi: 10.3390/jcm15166356

LensesMacular Diseases

Safety and efficacy of an extended macular vision intraocular lens (IOL) for age-related macular degeneration (AMD) in real-world settings

BMC Ophthalmol

Hengerer FH, Stanzel B, Hoyos-Chacon J, Suarez M, Beckers S, Busatto P, Badalà F

doi: 10.1186/s12886-025-04515-9

Macular Diseases

Age-related choroidal atrophy: A systematic review of multimodal imaging, clinical features, and differentiation from other forms of macular degeneration

Surv Ophthalmol

Lai A, Issa M, Pereira A, Ghafri MA, Dollin M, Hurley B, Chhablani J, Yan P

doi: 10.1016/j.survophthal.2025.12.005

Macular Diseases

Prevalence and associated features of reticular pseudodrusen in neovascular age-related macular degeneration in an Asian population

Am J Ophthalmol

Kikushima W, Gilead N, Sherif MZA, Zhang C, Jiang Z, Sun C, Ong C, Hong CH, Teo KYC, Chakravarthy U, Cheung CMG

doi: 10.1016/j.ajo.2026.02.011

Retinal DiseasesFurther Publications

Prevalence of choroidal naevi in Germany: a cross-sectional analysis of the BiDirect study

BMC Ophthalmol

Lever M, Schweig A, Berger K, Teismann H, Süsskind D, Ueffing M, Bechrakis NE, Stang A

doi: 10.1186/s12886-026-05129-5

Macular DiseasesRetinal Diseases

Trends in Prevalence and Incidence of Diabetic Retinal Disease Across Age Cohorts

Ophthalmol Retina

Chang AY, Yu Y, Cardillo S, Hubbard RA, VanderBeek BL

doi: 10.1016/j.oret.2026.03.007

Macular Diseases

Reduced Risk of Non-Neovascular AMD in Cancer Patients Treated with Immune Checkpoint Inhibitors: A Propensity-Matched Cohort Study

Am J Ophthalmol

Lishinsky-Fischer N, Gharra S, Nitzan I, Chowers I, Levy J

doi: 10.1016/j.ajo.2025.12.035

Related content

Faricimab for Polypoidal Choroidal Vasculopathy: 48-Week Results from the Phase 3b/4 SALWEEN Trial

Aflibercept 8 mg in Polypoidal Choroidal Vasculopathy: Post Hoc Analysis of the PULSAR Randomized Clinical Trial

Beyond Central Subfield Thickness: Early Multi-Slice Optical Coherence Tomography Structural Response After Faricimab Injection in Real-World Diabetic Macular Edema

Safety and efficacy of an extended macular vision intraocular lens (IOL) for age-related macular degeneration (AMD) in real-world settings

Age-related choroidal atrophy: A systematic review of multimodal imaging, clinical features, and differentiation from other forms of macular degeneration

Prevalence and associated features of reticular pseudodrusen in neovascular age-related macular degeneration in an Asian population

Prevalence of choroidal naevi in Germany: a cross-sectional analysis of the BiDirect study

Trends in Prevalence and Incidence of Diabetic Retinal Disease Across Age Cohorts

Reduced Risk of Non-Neovascular AMD in Cancer Patients Treated with Immune Checkpoint Inhibitors: A Propensity-Matched Cohort Study